Počet záznamov: 1
neoplázia endokrinná mnohopočetná, typ 1
SYS d018761 LBL 00000cx--j2200000---45-- 005 20240119201243.5 100 $a 19940523asloy0103----ba0 152 $b mesh 250 $a neoplázia endokrinná mnohopočetná, typ 1 $x BL $x BS $x CF $x CH $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SC $x SU $x TH $x UL $x UR $x VE $x VI $8 slo 300 1-
$a 95; MEA I, MEN I, & WERMER SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94 $8 eng 300 1-
$a Multiple Endocrine Neoplasia (1972-1994) $8 eng 330 1-
$a A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13). $8 eng 450 $a Neoplasia, Multiple Endocrine Type 1 $5 e $8 eng 450 $a Neoplasms, Multiple Endocrine Type 1 $5 e $8 eng 450 $a Wermer Syndrome $5 e $8 eng 450 $a nádory endokrinné mnohopočetné, typ 1 $5 e $8 slo 450 $a Wermerov syndróm $5 e $8 slo 550 $3 sllk_un_auth*d006961 $Y Hyperparathyroidism $5 B $a hyperparatyreoidizmus 550 $3 sllk_un_auth*d015043 $Y Zollinger-Ellison Syndrome $5 B $a Zollingerov-Ellisonov syndróm 550 $3 sllk_un_auth*d015408 $Y Gastrinoma $5 B $a gastrinóm 686 $a C04.588.322.400.500 686 $a C04.651.600.500 686 $a C04.700.630.500 686 $a C16.320.700.630.500 686 $a C19.344.400.500 750 $a Multiple Endocrine Neoplasia Type 1 $8 eng 801 -0
$a US $b DNLM $c 19940523 801 -2
$a SK $b BA006 $c 20020709 801 -2
$a SK $b BA006 $c 20190204 820 $a coordinate IM with specific endocrine/neoplasm pre-coordinates (IM) + specific histological type (IM) if pertinent $8 eng 980 $x M
Počet záznamov: 1